There was no evidence of carcinogenicity at the highest dose of phentermine (30 mg/kg) which is approximately 11 to 15 times the maximum recommended clinical dose of phentermine and topiramate extended-release 15 mg/92 mg based on AUC exposure
Before questioning the benefits of GLP-1 agonists, be sure your patient is not taking a steroid burst such as prednisone which is causing hyperglycemia
It is crucial to recognise that pre-existing gastroparesis or diabetic autonomic neuropathy may complicate the clinical picture
just be sure to seek out blends that create synergy between several active substances
This process requires adequate cardiovascular stability, proper hydration, and sufficient protein reserves
[DOI] [PMC free article] [PubMed] [Google Scholar] 173.Nielsen LB, Ploug KB, Swift P, rskov C, Jansen-Olesen I, Chiarelli F, Holst JJ, Hougaard P, Prksen S, Holl R, de Beaufort C, Gammeltoft S, Rorsman P, Mortensen HB, Hansen L